TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma - Pfaff, Elke; Remke, Marc; Sturm, Dominik; Benner, Axel; Witt, Hendrik; Milde, Till; Bueren, André von; Wittmann, Andrea; Schöttler, Anna; Jorch, Norbert; Graf, Norbert; Kulozik, Andreas; et al. (Journal of clinical oncology, 2010)
Gesehen am 28.04.2023